STAT3 and neoplasm: Glutamate released by tumor cells can promote the phosphorylation of STAT3 in neutrophils, transitioning them from a tumor-killing phenotype to an immunosuppressive phenotype, a process believed to represent a shift from N1 to N2 (Xiong et al., 2022a).